Funding to Support U.S. Pivotal Trial of CLAAS® Stroke Prevention Technology NASHUA, N.H. – Aug 6, 2020 – Conformal Medical, Inc., a medical device company focused on reducing stroke in patients with atrial fibrillation (AFib), today announced it has secured $85 million in Series C financing. The financing syndicate included participation from new investors Fidelity […]
Read MoreNews
Conformal is an innovative medical device developer dedicated to reducing stroke risk in patients with atrial fibrillation. A list of recent press releases and presentation can be found below.
We welcome inquiries about our technology and product pipeline. Click here to contact us.
Conformal Self-Adaptable LAA Closure Device: Initial Clinical Experience
Presentation by Molly Szerlip, MD On behalf of the Conformal EFS Investigators. Please view the Conformal Self-Adaptable LAA Closure Device presentation here: Szerlip CRT Presentation
Read MoreICE-Guided Implantation of the Conformal Left Atrial Appendage Closure Device: First Clinical Report
In this first report of ICE-guided LAAC with the novel Conformal LAAC Implant, implantation was feasible, safe and effective in achieving 100% closure. Please view the Sinai-Homolka poster presentation here: Sinai-Homolka – Conformal LAA Closure
Read MoreConformal Medical Announces First Left Atrial Appendage Closures Performed Under Conscious Sedation with its CLAAS Technology at AF Symposium 2020
Nashua, N.H. – January 22, 2020 – Conformal Medical, Inc. announced today the presentation of the first left atrial appendage closure (LAAC) cases with its unique CLAAS® Technology in patients under conscious sedation without general anesthesia. Drs. Petr Neuzil and Vivek Reddy will present “ICE-Guided Implantation of the Conformal Left Atrial Appendage Closure Device: First […]
Read MoreConformal Medical Announces Presentation of US Feasibility Study Data at TCT 2019 in San Francisco
NASHUA, N.H., Sept. 23, 2019 /PRNewswire/ — Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Closure (LAAC) System, will present data on the first human implants of its unique technology for the prevention of stroke in patients with atrial fibrillation (AFib) at the TCT 2019 meeting September 25, 2019 at 4:30pm. The study’s […]
Read MoreConformal Medical Announces First Human Use of Conformal LAA Seal for Stroke Prevention in US Feasibility Study
Nashua, NH – April 9, 2019 – Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, reports the first human use of its proprietary technology for the prevention of stroke in patients with atrial fibrillation (AFib). The case was performed by Robert Sommer, MD at New York-Presbyterian/Columbia University Medical Center […]
Read MoreConformal Medical Announces $9 million Series B Financing
Nashua, NH – December 3, 2018 – Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, has secured $9 million in Series B funding. Conformal is developing proprietary seal technology for the prevention of stroke in patients with atrial fibrillation (AFib). Over five million people in the United States have […]
Read More